Anlon Healthcare’s initial public offering (IPO) made a subdued debut on the stock market, reflecting cautious investor sentiment amid prevailing market volatility. Shares opened slightly above the issue price but showed limited upward momentum, signaling a muted response from both retail and institutional participants. Analysts suggest that while the company has a solid operational foundation in the healthcare sector, broader market conditions and investor preference for more liquid or high-growth stocks may have tempered demand.